Women Can Take Antidepressants During Pregnancy

Women Can Take Antidepressants During Pregnancy.
Women who study reliable antidepressants while pregnant do not raise the risk of a stillbirth or death of their baby in the first year of life, according to a obese new study. The findings stem from an analysis involving 30000 women in Denmark, Finland, Iceland, Norway and Sweden, who gave line to more than 1,6 million babies, in total, between 1996 and 2007. Close to 2 percent of the women took formula selective serotonin reuptake inhibitors (SSRIs), such as Prozac (fluoxetine) and Paxil (paroxetine), for depressive symptoms during their pregnancy.

The delve into team, led by Dr Olof Stephansson of the Karolinska Institute in Stockholm, Sweden, reports in the Jan 2, 2013 spring of the Journal of the American Medical Association that initially women taking an SSRI for dent did seem to live statistically higher rates of stillbirth and infant death. However, that uptick in imperil disappeared once they accounted for other factors, including the threat posed by despair and the mother's history of psychiatric disease or hospitalizations, the authors noted in a journal news release.

And "The aid study of more than 1,6 million births suggests that SSRI use during pregnancy was not associated with increased risks of stillbirth, neonatal eradication or postneonatal death," Stephansson's team reported. "The increased rates of stillbirth and postneonatal mortality amongst infants exposed to an SSRI during pregnancy were explained by the bareness of the underlying maternal psychiatric disease and unfavorable distribution of tender characteristics such as cigarette smoking and advanced maternal age," the authors added.

Depression during pregnancy affects between 7 percent and 19 percent of mothers-to-be in economically developed countries, the authors spiked out in the report. "Maternal sadness is associated with poorer pregnancy outcomes, including increased peril of preterm delivery, which in turn may cause neonatal morbidity and mortality".

The team acknowledged that use of SSRIs during pregnancy has been associated with confinement defects, neonatal withdrawal syndrome and pulmonary hypertension of the newborn, which is what led to the prevailing study. Although they found that the drugs posed no independent risk regarding stillbirth or infant death, the authors urged mothers and physicians to propose to SSRI use carefully home page. "Decisions pertaining to use of SSRIs during pregnancy must take into account other perinatal outcomes and the risks associated with maternal perceptual illness," Stephansson and colleagues concluded.